Merlintrader Trading Pub
Biotech catalyst, news and analysis PDUFA tracker
Merlintrader Trading Pub
Biotech catalyst, news and analysis PDUFA tracker
AI transparency: articles and reports are produced with the help of artificial intelligence and checked through a process that does not constitute specialist validation. They may contain errors: verify relevant information with independent sources. Read the full disclaimer.
Golden Dome $PL $BKSY $SATL
For years, “space” was mostly a story about launch costs and broadband dreams. In 2026 the narrative is shifting: satellites are becoming the nervous system of a new defence architecture built around missile warning, tracking and resilient communications
Cognition Therapeutics $CGTX
Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative, small-molecule oligomer antagonists for age-related degenerative disorders of the central nervous system, primarily Alzheimer's disease (AD) and Dementia with Lewy Bodies (DLB).
RGTI Rigetti Computing Inc
Rigetti is one of the few pure-play public quantum computing hardware names. It designs and manufactures superconducting quantum processors, integrates the control stack and cryogenics around them, and exposes these systems through a cloud platform so that enterprises, governments and researchers can experiment with quantum algorithms and hybrid quantum-classical workflows.
ALVO Alvotech Feb 2026
Alvotech is not a typical development-stage biotech: it is a vertically integrated biosimilar platform that already generates hundreds of millions of dollars in revenue from launched products like AVT02 (adalimumab) and AVT04 (ustekinumab), while also running a crowded late-stage pipeline. The stock sits in that awkward middle ground between “early growth” and “heavy balance sheet”, with over 1B$ of debt but also positive adjusted EBITDA and operating profit in the latest 9-month period.
CYN Cyngn Inc
Cyngn (ticker CYN) sits in a corner of the market that many traders only notice when the tape goes vertical: micro-cap industrial autonomy. This is not a classical biotech binary, not a cash-generating SaaS giant, and definitely not a clean “AI story” with nine-figure revenues. It is a company trying to turn a fairly sophisticated autonomy stack into a repeatable, contract-driven business in forklifts, tuggers and other industrial vehicles – while burning real money and living under the constant threat of dilution.
2026 The New Era – Watchlist Space-AI-Defense
2026 opens in a geopolitical environment that looks like a “Cold War 2.0” – but running at a much higher speed and across more domains than anything we have seen before. Classic threat pillars – nuclear deterrence, air and sea control, conventional superiority – are still there, but they have been reshaped by disruptive technologies that make them far more lethal and unpredictable.
BNAI Brand Engagement Network Inc
In mid-January we covered BNAI as a tiny, risky AI play with a handful of real enterprise projects and a fragile balance sheet. Two weeks later the stock has printed a 52-week range from $1.18 to an intraday high above $80, short interest has exploded, and the company rushed out multiple press releases on licensing, warrant exercises, debt conversion and a premium private placement. This note is meant to put everything back into one framework: what BEN actually does, what changed in January, how stretched the valuation looks, and which hard catalysts matter once the trading dust settles.
PLTR Palantir Technologies Inc Updated Feb 3
Deep dive on Palantir’s dual engine (government + commercial AI), the new U.S. Army Enterprise Agreement and the Innodata partnership for multimodal data in “rodeo analytics” – with an eye on 2026 catalysts.
SKYX Platforms Corp
SKYX wants to turn the ceiling into the “brain” of the home: a plug & play outlet that makes lights, fans and smart devices safer and easier to install, plus an AI-native platform built on NVIDIA’s cloud ecosystem. Revenues have climbed to record levels through Q3 2025 and the company has just secured new strategic and institutional funding ahead of big launches at Lowe’s and early smart city deployments.
NMRA Neumora Therapeutics
Deep dive on Neumora Therapeutics (NMRA): navacaprant reset, NMRA-511 Alzheimer’s agitation data, M4 franchise and a 2026–2027 catalyst map for biotech run-up traders. Educational only, not investment advice.
Space Defence & AI
When you line up the numbers on artificial intelligence in space operations, autonomous systems and new-generation missile defence, it becomes very clear we are not looking at a “nice theme” to trade for a few quarters. We are watching the birth of a structural, AI-native arms race that stretches easily over the next 20–30 years.
US Airline Sector 2026
The U.S. airline sector in early 2026 is the product of two overlapping cycles. The first is the post-COVID recovery wave: a violent rebound in demand, especially leisure and international, that allowed the big carriers to refill their cash tanks, repair balance sheets and renegotiate labor. The second is the return of classic airline constraints: high capital intensity, structurally volatile fuel costs, periodic labor shocks and the need to keep debt under control without sacrificing network relevance.
BNAI Brand Engagement Network DeepDive
AI platform targeting highly regulated clients. Q4 2025 marked a “turning point”: a top-10 pharma engagement project, the Skye Salud sovereign healthcare JV in Mexico, and a first step in cleaning up a heavily diluted balance sheet.
JFBR Jeffs Brands Ltd
Jeffs’ Brands Ltd is a tiny Israeli micro-cap originally built around a data-driven Amazon FBA portfolio. That legacy business is still there: roughly $13.7M revenue in FY2024 against a net loss of about $7.8M, with a very small equity value and high operating leverage. The last twelve months have been brutal for long-term holders, with a price trajectory closer to a ski slope than a growth story.
BNAI Brand Engagement Network Inc
AI platform for regulated clients. Q4 2025 pivot built on a top-10 pharma engagement project, the Skye Salud sovereign healthcare JV in Mexico and a first step of balance-sheet clean-up with Nasdaq compliance restored.
Briefing Space-AI-Defence stocks jan 14
Briefing Space-AI-Defence stocks Jan 14
Daily overview on defence, space and AI-linked military names: Grok enters Pentagon networks, MBDA strengthens its position in Brazil and space small caps swing between rational euphoria and technical risk.
DVLT Datavault AI Inc
Datavault AI Inc. (Nasdaq: DVLT) is a small/micro-cap technology company that wants to sit at the intersection of AI, Web3 and data monetization. It licenses a portfolio of patents and software platforms to tokenize and value “real-world assets” (RWA) – from genomic data and prescription flows to commodities and luxury goods – and still carries the legacy wireless-audio business acquired from WiSA.
SPACE & DEFENCE 2026
SIDU, ASTS, LUNR, ONDS and PL are not just “hot tickers”. Their satellites, landers, drones and imaging constellations are becoming building blocks of a Western answer to China’s dual-use space programs, Russia’s drone war and a world where infrastructure and data are contested every single day.
KODK Eastman Kodak Co
KODK (KODK) – TURNAROUND / ADVANCED MATERIALS & CHEMICALS Mid-cap industrial (≈$800M) in full transition: from legacy photography to commercial print, advanced materials & chemicals, EV battery electrodes and pharmaceutical manufacturing. $1B+ pension reversion completed, term debt cut to $200M,…
Encyclopedia of Social Trader Myths – Vol. 2
The slightly less polite, more cynical and more honest companion to the original Encyclopedia of Social Trader Myths. Same dark humour, more uncomfortable truths about how traders really behave on Stocktwits, Reddit, X and Discord.
